ProsTIC
@pros_tic
Followers
1K
Following
1K
Statuses
855
Prostate Cancer Theranostic & Imaging Centre of Excellence at the Peter MacCallum Cancer Centre (ProsTIC) / GU Oncology Multidisciplinary team. Funded by PCF.
Melbourne, Australia
Joined May 2020
3️⃣5️⃣0️⃣+ attendees 😎 2️⃣6️⃣+ countries 🌏 3️⃣8️⃣+ speakers 🗣️ 3️⃣ amazing days 🤩 This is #PSMA #theranostics 🚀 This is next-gen #PrecisionOncology in Practice 🎯 This is #ProsTIC24 💪 @PeterMacCC @DrMHofman
1
8
23
RT @AzadOncology: Thanks to @UniMelb for the Xmas present: promotion to Full Professor. Too many people to thank - my parents & brother, my…
0
10
0
🎉 Thrilled to announce the promotion of Dr. Arun Azad to PROFESSOR @AzadOncology A leader in uro-oncology, Professor Azad's groundbreaking work in prostate cancer has transformed care globally. Join us in congratulating him! 👏
2
4
41
Congrats Team @pros_tic ! A hyper-productive year. More to come in 2025 with results of VIOLET and AlphaBet clinical trials anticipated. @ButeauJames @LouiseKostos
Congratulations to @DrMHofman and the @pros_tic team for their relentless efforts and outstanding contributions!🏆👏 #Oncology #Theranostics #CancerResearch @Prof_IanD @ANZUPtrials @DrBenTran @AzadOncology
0
0
6
RT @oncodaily: Michael Hofman (@DrMHofman )‘s top 10 publications from 2024 which ProsTic (@pros_tic) contributed to
0
2
0
RT @DrYukselUrun: Congratulations to @DrMHofman and the @pros_tic team for their relentless efforts and outstanding contributions!🏆👏 #Oncol…
0
6
0
RT @DrMHofman: Very hard to pick but here are my top 10 publications from 2024 which team @pros_tic contributed to: ① (Jan’24, Lancet Onco…
0
38
0
@DrMHofman highlighting the best from an incredible portfolio of more than 60 publications this year. TEAM SCIENCE at its best.
Very hard to pick but here are my top 10 publications from 2024 which team @pros_tic contributed to: ① (Jan’24, Lancet Oncol) TheraP follow-up: Lu-177 PSMA-617 vs cabazitaxel in mCRPC ⇒ OS ~similar, better QoL. @Prof_IanD @ANZUPtrials ② (Feb’24, J Nucl Med) CAIX-peptide first-in-human study ⇒ High tumor uptake & new theranostics potential. @DrBenTran ③ (Mar’24, Eur Urol) LuTectomy ⇒ Lu-177 PSMA-617 pre-RP in high-risk PCa ⇒ Safe, high radiation doses achieved. @RenuEapen @ButeauJames ④ (Apr’24, Lancet) Commission ⇒ Surging PCa burden; calls for global strategies & research. @Prof_Nick_James ⑤ (May’24, Lancet Oncol) ENZA-p ⇒ Lu-177 PSMA-617 + enzalutamide ⇒ improved PFS in mCRPC. @drlouiseemmett ⑥ (Jun’24, Eur Urol) PSMA-PET in “nmCRPC” ⇒ Polymet disease ⇒ Worse survival vs conventional imaging. @ProfHadaschik ⑦ (Oct’24, Lancet Oncol) UpFrontPSMA ⇒ Lu-177 PSMA-617→docetaxel in high-vol mHSPC ⇒ Superior antitumor activity. @AzadOncology ⑧ (Oct'24, Eur Urol) APCCC ⇒ Expert consensus on advanced PCa imaging, therapy; highlights knowledge gaps. @Silke_Gillessen @AOmlin ⑨ (Nov’24, Lancet Oncol) Radiotherapy & Theranostics ⇒ Global disparities, need workforce expansion. @IAEANA ⑩ (Nov 28’24, Eur Urol Oncol) proPSMA outcomes follow-up ⇒ Baseline PSMA-PET nodal status predicts failure in high-risk PCa. @declangmurphy @veerukasi What a year in prostate theranostics !! @PCF_Science
0
0
4
@DragonMed_WU @amerseburger @declangmurphy @AndreaNecchi @SFreedlandMD Wonderful to see the event back in person in Shanghai! Congratulations to all the participants.
0
0
0
RT @DrMHofman: Longer follow-up from our landmark ProPSMA study just out @EurUrolOncol: PSMA nodal status is prognostic! At 3 years 70% of…
0
49
0
RT @pros_tic: @ProfKHerrmann joined #ProsTIC24 from Germany (Universitätsmedizin Essen) to share his vision for the next generation of ther…
0
4
0
LIVE on #ProsTICTV now is our final video from the #ProsTIC24 Preceptorship: Our theranostics and Lutetium-PSMA MDT featuring @DrMHofman @drlouiseemmett @ButeauJames @AzadOncology @declangmurphy @LouiseKostos @DrKerryJewell and @liz_medhurst 🩺⚕️
0
1
5
@ProfKHerrmann joined #ProsTIC24 from Germany (Universitätsmedizin Essen) to share his vision for the next generation of theranostic targets around the globe. Watch here: 🌏
0
4
7
RT @UroTeragLATAM: Today in #SMU24 we have the pleasure to listen to @declangmurphy @gu_onc about @pros_tic LuTectomy trial!! A potential…
0
2
0
RT @pros_tic: A real pleasure to host 2 days of intensive teaching and interaction on PSMA Theranostics @PeterMacCC with nuclear medicine a…
0
4
0
RT @pros_tic: @DrDavePattison is dual trained in Endocrinology and Nuclear Medicine. His research combines both of his specialities and all…
0
1
0
@DrDavePattison is dual trained in Endocrinology and Nuclear Medicine. His research combines both of his specialities and allows him to explore new radioligands in various cancer types including #prostatecancer. Watch his #ProsTIC24 talk here: 💉🧪
0
1
4
RT @pros_tic: Congrats to ProsTIC Director @DrMHofman: ranked as the leading researcher in nuclear medicine and Top 250 any field @australi…
0
8
0
Congrats to ProsTIC Director @DrMHofman: ranked as the leading researcher in nuclear medicine and Top 250 any field @australian Thanks to the entire team #TeamScience and our major funders that enable everyone @PCF_Science @AusCancer
@TheranosticsAus @SNM_MI @EANM_NucMed
Peter Mac has been named Australia's leading #cancer research institute in @australian newspaper's Research 2025 Magazine, and four of our researchers were named as leader in their field. Read more:
0
8
31
RT @PeterMacCC: Peter Mac has been named Australia's leading #cancer research institute in @australian newspaper's Research 2025 Magazine,…
0
8
0